DocSym
β
Searchsearch
Search
(B25.1+) Cytomegaloviral hepatitis
More details coming soon
152 046 in individuals diagnosis cytomegaloviral hepatitis confirmed
3 469 deaths with diagnosis cytomegaloviral hepatitis
2% mortality rate associated with the disease cytomegaloviral hepatitis
Diagnosis cytomegaloviral hepatitis is diagnosed Men are 6.31% more likely than Women
80 820
Men receive the diagnosis cytomegaloviral hepatitis
1 440 (1.8 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
71 226
Women receive the diagnosis cytomegaloviral hepatitis
2 029 (2.8 %)Died from this diagnosis.
Risk Group for the Disease cytomegaloviral hepatitis - Men and Women aged 0
In Men diagnosis is most often set at age 0-84
Less common in men the disease occurs at Age 85-95+Less common in women the disease occurs at Age 90-95+
In Women diagnosis is most often set at age 0-89
Disease Features cytomegaloviral hepatitis
Absence or low individual and public risk
Cytomegaloviral hepatitis - what does this mean
Cytomegaloviral hepatitis is a viral infection caused by the cytomegalovirus, which is a member of the herpes family. it can cause inflammation of the liver, leading to symptoms such as jaundice, abdominal pain, fatigue, and fever. the virus is typically spread through contact with infected bodily fluids, such as saliva, blood, and urine. it can also be spread through organ transplantation or blood transfusions.
What happens during the disease - cytomegaloviral hepatitis
Cytomegaloviral hepatitis is caused by infection with the cytomegalovirus (cmv). the virus enters the body through contact with bodily fluids, such as blood or saliva, and then infects the liver cells, resulting in inflammation and damage to the liver. this can lead to symptoms such as fatigue, jaundice, abdominal pain, and nausea. in some cases, it can even cause liver failure, which can be fatal.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Medical history and physical examination
- Blood tests to check for liver enzymes, bilirubin, and other markers of liver injury
- Liver biopsy to confirm diagnosis
- Imaging tests such as ultrasound, CT scan, or MRI to assess liver size and structure
- Viral load tests to measure the amount of virus in the body
- Genetic tests to identify the specific strain of virus
- Tissue culture to confirm the presence of the virus
Treatment and Medical Assistance
Main Goal: To reduce symptoms of Cytomegaloviral hepatitis and prevent the virus from spreading.
- Administer antiviral medications
- Provide supportive care through rest, nutrition and hydration
- Monitor liver enzymes and bilirubin levels
- Monitor for signs of liver failure
- Encourage lifestyle changes such as avoiding alcohol and smoking
- Monitor for signs of infection
- Prescribe medications for pain relief
- Administer immunoglobulins if needed
- Provide vaccinations to prevent other infections
- Provide counseling to help the patient cope with the disease
23 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Cytomegaloviral hepatitis - Prevention
Cytomegaloviral hepatitis can be prevented by avoiding contact with people who are infected, practicing good hygiene, and being vaccinated against the virus. additionally, it is important to practice safe sex, and to avoid sharing needles or other drug paraphernalia.